Michael Solon Lauer, MD
November 21st, 2013
Next Steps for the Randomized Registry Trial
Michael Solon Lauer, MD
Michael S. Lauer discusses his article titled “The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?”
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?